TRAVERE THERAPEUTICS INC (TVTX)
US89422G1076 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to TVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.1. This target is 163% above the current price.
TVTX was analyzed by 22 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about TVTX.
In the previous month the buy percentage consensus was at a similar level.
TVTX was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-27 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-03-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-16 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-01-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-12-18 | Stifel | Maintains | Hold -> Hold |
| 2023-12-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-05 | Citigroup | Upgrade | Neutral -> Buy |
| 2023-12-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-20 | Citigroup | Initiate | Neutral |
| 2023-10-25 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-09-29 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-09-22 | Guggenheim | Maintains | Buy -> Buy |
| 2023-09-22 | Barclays | Maintains | Overweight -> Overweight |
| 2023-09-22 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-09-22 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023-09-22 | B of A Securities | Maintains | Buy -> Buy |
| 2023-09-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-21 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-09-19 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023-09-06 | Evercore ISI Group | Reiterate | Outperform -> Outperform |
| 2023-08-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-21 | JP Morgan | Initiate | Overweight |
| 2023-07-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-06-21 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-06-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-22 | TD Cowen | Initiate | Outperform |
| 2023-05-02 | Guggenheim | Maintains | Buy |